Table 1.
Women’s Interagency HIV Study Participant Characteristics at Index Visit
| Characteristic, N (%) | HIV+ (N=1,315) | HIV− (N=557) | P Value |
|---|---|---|---|
| Number of falls since last visit | 0.98 | ||
| No fall | 1069 (81.3) | 453 (81.3) | |
| One fall | 118 (9.0) | 51 (9.2) | |
| More than one fall | 128 (9.7) | 53 (9.5) | |
| Injurious falls | 86 (6.5) | 40 (7.2) | 0.6 |
| Age, years, median (IQR) | 49 (43,55) | 47 (40,54) | <0.001 |
| Education level high school or greater | 872 (66.4) | 382 (68.7) | 0.32 |
| Annual Income ≥$12,000/yr | 624 (49.4) | 285 (53.8) | 0.09 |
| WIHS Site | 0.06 | ||
| Bronx/Manhattan, NY | 234 (17.8) | 126 (22.6) | |
| Brooklyn, NY | 239 (18.2) | 95 (17.1) | |
| Washington DC | 215 (16.3) | 93 (16.7) | |
| San Francisco, CA | 232 (17.6) | 106 (19.0) | |
| Chicago, IL | 215 (16.3) | 82 (14.7) | |
| Southern sites | 180 (13.7) | 55 (9.9) | |
| Race | 0.22 | ||
| White | 226 (17.2) | 78 (14.0) | |
| Black | 917 (69.7) | 400 (71.8) | |
| Other | 172 (13.1) | 79 (14.2) | |
| Smoking status | <0.001 | ||
| Never | 395 (30.7) | 127 (23.3) | |
| Current | 480 (37.3) | 256 (47.0) | |
| Former | 413 (32.1) | 162 (29.7) | |
| Crack, Cocaine, or Heroin use | <0.001 | ||
| Never | 562 (42.8) | 210 (37.7) | |
| Current | 77 (5.9) | 60 (10.8) | |
| Former | 674 (51.3) | 287 (51.5) | |
| Marijuana use | <0.001 | ||
| Never | 383 (29.1) | 121 (21.7) | |
| Current | 230 (17.5) | 151 (27.1) | |
| Former | 701 (53.3) | 285 (51.2) | |
| Alcohol consumption * | <0.001 | ||
| Abstainer/None | 717 (55.7) | 241 (44.2) | |
| Light (< 3 drinks/week) | 427 (33.2) | 198 (36.3) | |
| Moderate (3–13 drinks/week) | 50 (3.9) | 28 (5.1) | |
| Heavy (≥14 drinks/week) | 93 (7.2) | 78 (14.3) | |
| Hepatitis C virus seropositive | 246 (18.8) | 66 (11.9) | <0.001 |
| Diabetes Mellitus | 294 (22.4) | 135 (24.2) | 0.38 |
| Hypertension | 619 (47.1) | 258 (46.3) | 0.77 |
| Renal disease † | 137 (10.8) | 31 (5.8) | <0.001 |
| Depressive symptoms †† | 363 (28.6) | 147 (27.3) | 0.59 |
| Peripheral neuropathy | 262 (19.9) | 75 (13.5) | <0.001 |
| Obesity ‡ | 569 (45.3) | 296 (55.7) | <0.001 |
| Cognitive complaints | 152 (11.6) | 57 (10.2) | 0.41 |
| ART use at index visit | 1182 (89.9) | N/A | N/A |
| Undetectable HIV RNA viral load ** | 783 (62.5) | N/A | N/A |
| Nadir CD4+ cell count (cells/μl), median (IQR) | 257(135,428) | N/A | N/A |
| CD4+ cell count at index visit (cells/μl), median (IQR) | 580 (372,776) | N/A | N/A |
| Prior AIDS defining illness ever | 480 (36.5) | N/A | N/A |
*
Alcohol use: light (< 3 drinks/wk), moderate (3–13 drinks/wk), (≥14 drinks/wk)
†
Estimated Glomerular Filtration Rate <60 mL/min by MDRD (Modification of Diet in Renal Disease) equation defined as GFR (mL/min/1.73 m2) = 175 × (Scr)−1.154 × (Age)−0.203 × (0.742 if female) × (1.212 if African American)
‡
Body Mass Index ≥30kg/m2
††
Center for Epidemiologic Studies Depression Scale (CES-D) ≥ 16
**
<20copies/mL